Evommune

Yahoo Finance • 21 hours ago

Evommune surges on mid-stage trial win for eczema therapy

[$10 Banknote Stacking, Green Up Arrow Rise] spawns Evommune (EVMN [https://seekingalpha.com/symbol/EVMN]) added more than ~50% in early trading on Tuesday after the biotech announced a mid-stage trial win for EVO301, its experimental the... Full story